A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers | MicrobiomeTrials← Back to trialsNCT07798505
A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-08-17Est. Completion: 2027-04-30
Enrollment target: 40 participants Locations- Worldwide Clinical Trials, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Overweight and Obese Adults
Obesity is a complex disease and a major risk factor for cardiovascular and metabolic disorders, particularly atheroscle…
Istanbul, Turkey (Türkiye)Est. completion Sep 30, 2026
Cryptococcal InfectionCryptococcal PneumoniaPulmonary CryptococcosisCryptococcal MeningitisCryptococcosis
The protocol will be carried out in accordance with International Council for Harmonisation of Technical Requirements fo…